Acorafloxacin

N/A

Report date: 2026/03/04 20:01:44
NMEQIDP

Base Information

Drug NameAcorafloxacin
Drug Alias Name阿考沙星acorafloxacineacorafloxacino阿雷沙星acorafloxacinum +[10] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionTopoisomerase (DNA) II alpha inhibitorsTopoisomerase IV inhibitorsBacterial DNA gyrase inhibitors
TargetsTopoisomerase (DNA) II alphaTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsComplicated Skin and Soft Tissue InfectionsPneumonia, Bacterial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPoland +[6] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson Innovative Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFuriex Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsComplicated Skin and Soft Tissue InfectionsPneumonia, Bacterial

Other Information

ATC CodeN/A
Related LinksKEGG